Literature DB >> 11248162

From the molecule to the clinic--inhibiting HER2 to treat breast cancer.

E A Eisenhauer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248162     DOI: 10.1056/NEJM200103153441110

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

Review 1.  Pharmacogenomics and drug development.

Authors:  Yingying Guo; Steven Shafer; Paul Weller; Jonathan Usuka; Gary Peltz
Journal:  Pharmacogenomics       Date:  2005-12       Impact factor: 2.533

2.  HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial Carcinomas.

Authors:  Klaus Aumayr; Tobias Klatte; Barbara Neudert; Peter Birner; Shahrokh Shariat; Manuela Schmidinger; Martin Susani; Andrea Haitel
Journal:  Pathol Oncol Res       Date:  2017-07-28       Impact factor: 3.201

3.  Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false-positive or false-negative immunohistochemistry?

Authors:  Ciara Barrett; Hilary Magee; Denise O'Toole; Sinead Daly; Michael Jeffers
Journal:  J Clin Pathol       Date:  2006-07-05       Impact factor: 3.411

Review 4.  Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2.

Authors:  Kate McKeage; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Genomics and drug response.

Authors:  Liewei Wang; Howard L McLeod; Richard M Weinshilboum
Journal:  N Engl J Med       Date:  2011-03-24       Impact factor: 91.245

Review 6.  A decade's studies on metastasis of hepatocellular carcinoma.

Authors:  Zhao-You Tang; Sheng-Long Ye; Yin-Kun Liu; Lun-Xiu Qin; Hui-Chuan Sun; Qin-Hai Ye; Lu Wang; Jian Zhou; Shuang-Jian Qiu; Yan Li; Xue-Ning Ji; Hu Liu; Jing-Ling Xia; Zhi-Quan Wu; Jia Fan; Zeng-Chen Ma; Xin-Da Zhou; Zhi-Ying Lin; Kang-Da Liu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-18       Impact factor: 4.553

7.  NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis.

Authors:  Debajit K Biswas; Qian Shi; Shanon Baily; Ian Strickland; Sankar Ghosh; Arthur B Pardee; J Dirk Iglehart
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

8.  Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo.

Authors:  Manran Liu; Xiaoming Ju; Nicole E Willmarth; Mathew C Casimiro; John Ojeifo; Toshiyuki Sakamaki; Sanjay Katiyar; Xuanmao Jiao; Vladimir M Popov; Zuoren Yu; Kongming Wu; David Joyce; Chenguang Wang; Richard G Pestell
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

Review 9.  Autocrine stimulation in colorectal carcinoma (CRC): positive autocrine loops in human colorectal carcinoma and applicable significance of blocking the loops.

Authors:  Wen-Jing Ruan; Mao-De Lai
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

10.  Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology.

Authors:  Gopinath Sutendra; Evangelos D Michelakis
Journal:  Front Oncol       Date:  2013-03-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.